Literature DB >> 23327449

Higher pain sensitivity and lower muscle strength in postmenonpausal women with early rheumatoid arthritis compared with age-matched healthy women--a pilot study.

Cecilia Fridén1, Ulrika Thoors, Birgitta Glenmark, Eva Kosek, Birgitta Nordmark, Ingrid E Lundberg, Christina H Opava.   

Abstract

PURPOSE: The purpose of the study was to examine muscle strength and pain sensitivity in postmenopausal women with and without RA.
METHODS: Ten women with and ten without early RA were recruited. All were postmenopausal, and did not use hormone replacement therapy. Measurements of isokinetic muscle strength in knee flexors/extensors, hand grip strength, timed standing, pressure pain thresholds (PPT), suprathreshold pressure pain, and segmental and plurisegmental endogenous pain inhibitory mechanisms during muscle contraction were assessed.
RESULTS: Participants with early RA were weaker in knee flexors, in hand grip strength and they needed more time for the timed standing. Women with early RA had higher sensitivity to threshold pain and suprathreshold pressure pain compared to women without RA. PPTs increased in the contracting muscle as well as in a distant resting muscle during static contractions in both groups.
CONCLUSIONS: Our results indicate differences in muscular strength between postmenopausal women with and without RA. Furthermore, women with RA had decreased PPT and hyperalgesia, but no dysfunction of segmental or plurisegmental pain inhibitory mechanisms during static exercise compared to healthy controls. The normal function of endogenous pain inhibitory mechanisms despite chronic pain in women with RA might contribute to the good effects of physical activity previously reported.

Entities:  

Mesh:

Year:  2013        PMID: 23327449     DOI: 10.3109/09638288.2012.731469

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  6 in total

1.  Intrinsic Brain Connectivity in Chronic Pain: A Resting-State fMRI Study in Patients with Rheumatoid Arthritis.

Authors:  Pär Flodin; Sofia Martinsen; Reem Altawil; Eva Waldheim; Jon Lampa; Eva Kosek; Peter Fransson
Journal:  Front Hum Neurosci       Date:  2016-03-15       Impact factor: 3.169

2.  Long-term, health-enhancing physical activity is associated with reduction of pain but not pain sensitivity or improved exercise-induced hypoalgesia in persons with rheumatoid arthritis.

Authors:  Monika Löfgren; Christina H Opava; Ingrid Demmelmaier; Cecilia Fridén; Ingrid E Lundberg; Birgitta Nordgren; Eva Kosek
Journal:  Arthritis Res Ther       Date:  2018-11-26       Impact factor: 5.156

Review 3.  Acute effects of exercise on pain symptoms, clinical inflammatory markers and inflammatory cytokines in people with rheumatoid arthritis: a systematic literature review.

Authors:  Christopher Balchin; Ai Lyn Tan; Joshua Golding; Lesley-Anne Bissell; Oliver J Wilson; Jim McKenna; Antonios Stavropoulos-Kalinoglou
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-08-16       Impact factor: 3.625

4.  Predictors of unacceptable pain with and without low inflammation over 5 years in early rheumatoid arthritis-an inception cohort study.

Authors:  Anna Eberhard; Stefan Bergman; Thomas Mandl; Tor Olofsson; Maria Rydholm; Lennart Jacobsson; Carl Turesson
Journal:  Arthritis Res Ther       Date:  2021-06-14       Impact factor: 5.156

5.  Pain sensitivity at rest and during muscle contraction in persons with rheumatoid arthritis: a substudy within the Physical Activity in Rheumatoid Arthritis 2010 study.

Authors:  Monika Löfgren; Christina H Opava; Ingrid Demmelmaier; Cecilia Fridén; Ingrid E Lundberg; Birgitta Nordgren; Eva Kosek
Journal:  Arthritis Res Ther       Date:  2018-03-15       Impact factor: 5.156

6.  Distinct aberrations in cerebral pain processing differentiating patients with fibromyalgia from patients with rheumatoid arthritis.

Authors:  Angelica Sandström; Isabel Ellerbrock; Monika Löfgren; Reem Altawil; Indre Bileviciute-Ljungar; Jon Lampa; Eva Kosek
Journal:  Pain       Date:  2022-03-01       Impact factor: 7.926

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.